article thumbnail

Insights: Making Technology Transfer and IP Commercialization Work

socalTECH

For today''s Insights and Opinions section, we''re sharing an article on how to make technology transfer and IP commercialization work , from Siemer and Associates and Siemer Ventures'' Ivan Nikkhoo. Over time, some of this IP has made it to market helping create new products and industries. Results have been mixed. Continued.).

IP 159
article thumbnail

Ligand Buys IP From AstraZeneca

socalTECH

According to Ligand, it paid $2.75M for the IP and interest in future milestones and royalties for MEDI-528, an IL-9 antibody program being developed by MedImmune. The compound has possible applications in treating asthma.

IP 140
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

53 Questions Developers Should Ask Innovators

TechEmpower

Even when they have talked to multiple developers or development firms, we’re often the first to ask basic questions like “Who are your customers?” ” or “Are you developing for desktop, tablet, mobile, or all three?” The innovator/developer relationship needs to be a conversation.

Develop 520
article thumbnail

Vitesse In IP License Deal With Freescale

socalTECH

Camarillo-based Vitesse Semiconductor , which develops high speed, integrated circuits for the networking market, reported today that it has licensed its Gigabit Ethernet IP cores to Freescale. Financial impact of the licensing win was not disclosed.

IP 147
article thumbnail

Intellectual Property – Worthless To A Startup, Priceless To A Big Dumb Company

InfoChachkie

Intellectual Property (IP) is an ugly thing at a startup. However, to a Big Dumb Company (BDC), a startup’s IP is a thing of beauty. How can IP be worthless to a startup yet very worthwhile to a BDC? Because IP has intrinsic value, but only in the right hands. Yet, it does nothing to help you execute your business model.

IP 256
article thumbnail

Do You Really Own Your IP?

SoCal Tech Calendar

Thursday, September 10, 2009 -- Do You Really Own Your IP? Many companies, even those that are considered IP-savvy, have hidden problems with ownership of their valuable IP rights. Finding and addressing these problems is not difficult, but not finding them until a conflict develops can be devastating.

IP 100
article thumbnail

Imprimis Pharmaceuticals Licenses IP

socalTECH

Imprimis said it is developing innovations based on technology from the compounding pharmacy operations of Buderer. Imprimis said it is in the process of filing for a patent on those new IP assets. Financial details of the licensing deal were not announced. The company did not say what segment of the market the new assets would target.

IP 100